ATORVASTATIN LANDMARK PROGRAM Trademark

Trademark Overview


On Wednesday, July 9, 2003, a trademark application was filed for ATORVASTATIN LANDMARK PROGRAM with the United States Patent and Trademark Office. The USPTO has given the ATORVASTATIN LANDMARK PROGRAM trademark a serial number of 78271918. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 16, 2011. This trademark is owned by Pfizer Ireland Pharmaceuticals. The ATORVASTATIN LANDMARK PROGRAM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and Scientific research, namely, conducting clinical trials

General Information


Serial Number78271918
Word MarkATORVASTATIN LANDMARK PROGRAM
Filing DateWednesday, July 9, 2003
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 16, 2011
Registration Number2950116
Registration DateTuesday, May 10, 2005
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 23, 2004

Trademark Statements


Disclaimer with Predetermined Text"ATORVASTATIN or PROGRAM"
Goods and ServicesMedical and Scientific research, namely, conducting clinical trials
Pseudo MarkATORVASTATIN LAND MARK PROGRAM

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 16, 2011
Primary Code042
First Use Anywhere DateTuesday, September 30, 2003
First Use In Commerce DateTuesday, September 30, 2003

Trademark Owner History


Party NamePFIZER IRELAND PHARMACEUTICALS
Party Type31 - New Owner After Registration
Legal Entity Type02 - Partnership
AddressDUBLIN
IE

Party NamePfizer Ireland Pharmaceuticals
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDublin
IE

Party NamePfizer Ireland Pharmaceuticals
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDublin
IE

Party NamePfizer Ireland Pharmaceuticals
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDublin
IE

Trademark Events


Event DateEvent Description
Friday, December 16, 2011CANCELLED SEC. 8 (6-YR)
Wednesday, December 20, 2006AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, May 10, 2005REGISTERED-PRINCIPAL REGISTER
Wednesday, February 16, 2005LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, February 15, 2005ASSIGNED TO LIE
Tuesday, January 25, 2005ASSIGNED TO LIE
Sunday, January 9, 2005ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, November 26, 2004STATEMENT OF USE PROCESSING COMPLETE
Tuesday, November 16, 2004USE AMENDMENT FILED
Friday, November 26, 2004EXTENSION 1 GRANTED
Tuesday, November 16, 2004EXTENSION 1 FILED
Wednesday, November 17, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 16, 2004TEAS STATEMENT OF USE RECEIVED
Tuesday, November 16, 2004TEAS EXTENSION RECEIVED
Tuesday, June 15, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 23, 2004PUBLISHED FOR OPPOSITION
Wednesday, March 3, 2004NOTICE OF PUBLICATION
Friday, January 23, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 12, 2004EXAMINER'S AMENDMENT MAILED
Sunday, January 11, 2004ASSIGNED TO EXAMINER